三七总皂苷联合顺铂对肝癌细胞HepG2和SMMC-7721增殖、迁移、侵袭及凋亡的影响-东南大学学报医学版

三七总皂苷联合顺铂对肝癌细胞HepG2和SMMC-7721增殖、迁移、侵袭及凋亡的影响

单位：1. 泰州市人民医院感染科, 江苏泰州 225300;
2. 东南大学附属第二医院, 江苏南京 210003

分类号：R735.7;R730.5

出版年·卷·期（页码）：2017·36·第三期（383-389）

摘要：

目的：探讨三七总皂苷（PNS）联合顺铂（DDP）对肝癌细胞HepG2和SMMC-7721增殖、迁移、侵袭及凋亡的影响及其可能机制。方法：采用四甲基偶氮唑盐比色法（MTT法）检测不同浓度PNS和DDP分别及特定浓度联合处理对肝癌细胞HepG2和SMMC-7721增殖的作用，划痕实验检测肝癌细胞迁移的改变，Transwell小室实验检测肝癌细胞侵袭的改变，流式细胞术检测其对肝癌细胞凋亡的影响，蛋白质印迹法测定蛋白表达水平的改变。结果：应用PNS和DDP均能抑制肝癌细胞的增殖，呈现剂量-效应关系；PNS （200 μmol·L^-1）联合顺铂（5 μmol·L^-1）可显著抑制肝癌细胞增殖、迁移及侵袭的能力，增加细胞凋亡率；两者联合可降低肝癌细胞抗凋亡蛋白Bcl-2的表达，增加凋亡蛋白Bax的表达。结论：PNS联合DDP可显著抑制肝癌细胞HepG2和SMMC-7721的增殖，且能显著降低肝癌细胞迁移和侵袭的能力，增加肝癌细胞的凋亡。

Objective:To investigate the effects and mechanism of Panax notoginseng saponins(PNS)in combination with cisplatin(DDP)on the HepG2 and SMMC-7721 cells. Methods:The cellular proliferation of HepG2 and SMMC-7721 cells treated with PNS and DDP at the indicated concentrations was detected by MTT assay. The migration and invasion of HCC cells were detected by wound healing assay and matrigel invasion assay. Flow cytometry assay was used to analyze the changes of cell apoptosis. The protein expression was measured by western blot assay. Results:PNS and DDP inhibited cell viability of HCC cells in a dose-dependent manner. PNS combined with DDP significantly suppressed the cell growth, migration and invasion of HCC cells. Besides, PNS in combination with DDP could significantly decrease the expression of Bcl-2 and increase the expression of Bax to induce the apoptosis of HCC cells. Conclusion:PNS in combination with DDP can inhibit cell growth, migration and invasion and promote the apoptosis of HCC cells.

参考文献：

[1] CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[2] TOMULEASA C,SORITAU O,FISCHER-FODOR E,et al.Arsenic trioxide plus cisplatin/interferon alpha-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma[J].Hematology/oncology and stem cell therapy,2011,4(2):60-66.
[3] ALLI E,SHARMA V B,HARTMAN A R,et al.Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells[J].BMC Pharmacology,2011,11(1):1-12.
[4] 俞谦,孙为豪,刘顺英,等.奥曲肽联合特异性COX-2抑制剂对肝癌细胞的抑制作用[J].东南大学学报:医学版,2005,24(6):363-367.
[5] 王婷.三七总皂苷抗肿瘤与耐药逆转作用的研究进展[J].医学综述,2011,17(7):990-992.
[6] 陈刚,唐晓军,郑勤,等.载吉西他滨磁性白蛋白纳米球的制备及其对肝癌细胞生长的抑制作用[J].现代医学,2016,44(4):450-454.
[7] ENSMINGER W D.Intrahepatic arterial infusion of chemotherapy:pharmacologic principles[J].Semin Oncol,2002,29(2):119-125.
[8] ALEXANDRE J,TIGAUD J M,GROSS-GOUPIL M,et al.Combination of topotecan and oxaliplatin in inoperable hepatocellular cancer patients[J].Am J Clin Oncol,2002,25(2):198-203.
[9] WU T,MUNRO A J,LIU G,et al.Chinese medical herbs for chemotherapy side effects in colorectal cancer patients[J].Cochrane DB Syst Rev,2005,5(1):85-86.
[10] XIANZHI C,ZHANDONG L,NING Z,et al.Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese Medicine and chemotherapy[J].Chin J Integr Med,2012,18(8):626-628.
[11] 刘丽丽,刘艳娥,房国涛.三七总皂苷逆转乳腺癌细胞MCF-7/ADM多药耐药的实验研究[J].时珍国医国药,2008,19(4):954-956.
[12] 陈培丰,刘鲁明,陈震等.参三七醇提取液抑制肿瘤肝侵袭作用机理的实验研究[J].中国中医药科技,2007,14(2):96-97.
[13] 程桂丹,陆枫林.肝癌中基质金属蛋白酶及其抑制因子的研究进展[J].东南大学学报:医学版,2010,29(2):215-220.
[14] KUNNUMAKKARA A B,DIAGARADJANE P,ANAND P,et al.Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1,COX-2,MMP-9,VEGF and CXCR4 expression in an orthotopic mouse model[J].Int J Cancer,2009,125(9):2187-2197.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录